Research shows the fall switch to Standard Time causes a deeper mood slump than the spring jump into Daylight Saving Time.

Invivyd, Inc. (NASDAQ:IVVD) Q4 2025 Earnings Call Transcript March 5, 2026 Invivyd, Inc. misses on earnings expectations. Reported EPS is $-0.06428 EPS, expectations were $-0.06. Operator: Good day, ...

Elia projected, "On a projected basis, we anticipate suitable for robust assessment of VYD2311 effectiveness if the clinical performance of VYD2311 matches our modeling and prior experience with COVID ...

Achieved Q4 2025 PEMGARDA® (pemivibart) net product revenue of $17.2 million, representing 25% growth year-over-year and 31% growth quarter-over-quarter2025 year-end cash and cash equivalents of $226.

Members of Congress received a briefing on Tuesday regarding the military actions, prompting calls for a vote to clarify President Trump's authority to engage in war with Iran.

Progyny (PGNY) looks undervalued at 9.3x forward P/E, with strong cash flow, buybacks, and ~60% upside to $28—see the 2026–27 ...

"Basically they come in and say, 'we will take every one of you when you get your license,'" a program instructor said.

Promoted by Dr Krishna Ella, the vaccine manufacturer serves both domestic and export markets and remains entirely ...

Almost a quarter of Florida’s residents who should be screened for this cancer aren't up-to-date with widely accepted ...

Trump also invited the men’s team to the State of the Union during a Sunday night call that included FBI Director Kash Patel.

Explore Pfizer’s evolving pipeline strategy, expanding into oncology and obesity to drive growth beyond its COVID-19 success.

Fourth quarter revenue of $198 million, a year-over-year increase of 18% as reported, 14% organic with continued momentum in orders in the quarterFull year 2025 revenue of $738 million, a ...